Breathtec Biomed­i­cal does not say why stock is up

Stockwatch Daily - - HEALTH CARE - Mr. Michael Sadhra re­ports

AT THE re­quest of the In­vest­ment In­dus­try Reg­u­la­tory Or­ga­ni­za­tion of Canada, Breathtec Biomed­i­cal Inc. has con­firmed that its man­age­ment is un­aware of any ma­te­rial change in the op­er­a­tions of the com­pany that would ac­count for the re­cent mar­ket ac­tiv­ity. The com­pany will con­tinue to pro­vide up­dates of any ma­te­rial changes if and when they oc­cur.

About Breathtec Biomed­i­cal Inc

Breathtec Biomed­i­cal was formed to pro­pel in­no­va­tive re­search in the area of airborne anal­y­sis as a med­i­cal screen­ing tool. The com­pany’s ef­forts are aimed at lead­ing the devel­op­ment of com­mer­cially vi­able meth­ods for the early screen­ing of cer­tain pathogens. The com­pany’s pri­mary av­enue of in­ves­ti­ga­tion is fo­cused on in­no­va­tion and ad­vances in the field of spe­cial­ized mass spec­trom­e­try.

We seek Safe Har­bor. Ra­j­paul At­tari­wala, David Levine, Michael S M Sadhra

(BTH) Shares: 38,082,698

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.